1,062
Views
10
CrossRef citations to date
0
Altmetric
Report

Trends in capacity utilization for therapeutic monoclonal antibody production

Pages 151-156 | Received 01 Dec 2008, Accepted 08 Jan 2008, Published online: 01 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Robert D. Gay, Adam W. Clarke, Zehra Elgundi, Teresa Domagala, Raina J. Simpson, Nga B. Le, Anthony G. Doyle & Phil A. Jennings. (2010) Anti-TNFα domain antibody construct CEP-37247. mAbs 2:6, pages 625-638.
Read now

Articles from other publishers (9)

Karolis Jankauskas & Suzanne S. Farid. (2019) Multi-objective biopharma capacity planning under uncertainty using a flexible genetic algorithm approach. Computers & Chemical Engineering 128, pages 35-52.
Crossref
Rashmi Kshirsagar & Thomas Ryll. 2018. New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins. New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins 51 74 .
Fabian Steinebach, Thomas Müller-Späth & Massimo Morbidelli. (2016) Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production. Biotechnology Journal 11:9, pages 1126-1141.
Crossref
William C. Yang, Daniel F. Minkler, Rashmi Kshirsagar, Thomas Ryll & Yao-Ming Huang. (2016) Concentrated fed-batch cell culture increases manufacturing capacity without additional volumetric capacity. Journal of Biotechnology 217, pages 1-11.
Crossref
Stefan R. Schmidt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals 1 24 .
Seshu Tummala, Michael Titus, Lee Wilson, Chunhua Wang, Carlo Ciatto, Greg Thill, Donald Foster, Chen Li, Zoltan Szabo, Andras Guttman, Brian Bettencourt, Muthuswamy Jayaraman, Jack Deroot, David Kocisko, Stuart Pollard, Klaus Charisse, Satya Kuchimanchi, Greg Hinkle, Stuart Milstein, Rachel Meyers, Shiaw‐Lin Wu, Barry L. Karger & Anthony Rossomando. (2013) Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals. Biotechnology Progress 29:2, pages 415-424.
Crossref
Gesine Pless-Petig, Martin Metzenmacher, Tobias R Türk & Ursula Rauen. (2012) Aggravation of cold-induced injury in Vero-B4 cells by RPMI 1640 medium – Identification of the responsible medium components. BMC Biotechnology 12:1.
Crossref
Xinzhao Grace Jiang, Izydor Apostol, Quanzhou Luo, Jeffrey Lewis, Ronald KeenerIIIIII, Shun Luo, Matthew Jerums, Xin Zhang, Jette Wypych & Gang Huang. (2012) Quantification of protein posttranslational modifications using stable isotope and mass spectrometry. Analytical Biochemistry 421:2, pages 506-516.
Crossref
James Kaufman & Nicholas Kalaitzandonakes. (2011) The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticals. Journal of Commercial Biotechnology 17:2, pages 173-182.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.